(Q34155549)

31 July 2017

1 reference

title

Anxiety, depression, and insomnia (English)

1 reference

31 July 2017

0 references

Michele M Larzelere

1

1 reference

31 July 2017

Pamela Wiseman

series ordinal

2

1 reference

31 July 2017

publication date

1 June 2002

1 reference

Primary Care: Clinics in Office Practice

31 July 2017

published in

1 reference

31 July 2017

volume

29

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

339-60, vii

1 reference

The use of complementary and alternative therapies to treat anxiety and depression in the United States.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Why patients use alternative medicine: results of a national study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Unconventional medicine in the United States. Prevalence, costs, and patterns of use

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Epidemiology of depression in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

The functioning and well-being of depressed patients. Results from the Medical Outcomes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Health care costs of primary care patients with recognized depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

The Use of Herbal Alternative Medicines in Neuropsychiatry: A Report of the ANPA Committee on Research

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

St John's wort: Prozac from the plant kingdom.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

A review of herbal medicines for psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

St John's wort for depression: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Comparison of St John's wort and imipramine for treating depression: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Effectiveness of St John's wort in major depression: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Potential treatment for subthreshold and mild depression: a comparison of St. John's wort extracts and fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Adverse effects of herbal drugs in dermatology

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Effect of antenatal exposure to Saint John's wort (Hypericum) on neurobehavior of developing mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Effect of prenatally administered hypericum (St John's wort) on growth and physical maturation of mouse offspring.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Acute heart transplant rejection due to Saint John's wort

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Indinavir concentrations and St John's wort.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

St John's wort interaction with digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Safety of St John's wort (Hypericum perforatum)

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

The Cause and Pathogenesis of the Eosinophilia-Myalgia Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Fluoxetine: adverse effects and drug-drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

SAMe (S-adenosylmethionine).

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

S-adenosylmethionine blood levels in major depression: changes with drug treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Dehydroepiandrosterone (DHEA) treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Dehydroepiandrosterone treatment of midlife dysthymia.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

DHEA: dehydroepiandrosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Serum and red blood cell folate in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Nutrition and depression: the role of folate

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Vitamin B(12) deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

The influence of physical activity on mental well-being.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

A randomized controlled trial of progressive resistance training in depressed elders.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Effects of exercise training on older patients with major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Comparing aerobic with nonaerobic forms of exercise in the treatment of clinical depression: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Clinical research on the therapeutic effect of the electro-acupuncture treatment in patients with depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

The benefit from whole body acupuncture in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: a randomized comparison with electroconvulsive therapy (ECT) and imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava)

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Efficacy of kava extract for treating anxiety: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Kava: Piper methysticum.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Physical activity and psychological well-being: knowledge base, current issues, and caveats

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Physical activity and mental health: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

A meta-analysis on the anxiety-reducing effects of acute and chronic exercise. Outcomes and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Differential effects of relaxation techniques on trait anxiety: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Autogenic training for stress and anxiety: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

The clinical use of mindfulness meditation for the self-regulation of chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

[Acupuncture in patients with minor depressive episodes and generalized anxiety. Results of an experimental study]

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

A review of 12 commonly used medicinal herbs

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Quantifying the effects of mild sedatives

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Effect of valerian on human sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Critical evaluation of the effect of valerian extract on sleep structure and sleep quality

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

The influence of valerian treatment on "reaction time, alertness and concentration" in volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Melatonin, circadian rhythms, and sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

A critical assessment of the melatonin effect on sleep in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Melatonin in medically ill patients with insomnia: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Facilitation of Benzodiazepine Discontinuation by Melatonin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Improvement of sleep quality in elderly people by controlled-release melatonin.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

The effects of acute and chronic exercise on sleep. A meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

An evaluation of behavioral treatments for insomnia in the older adult

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Nondrug Treatment Trials in Psychophysiologic Insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Effectiveness of combined triazolam-behavioral therapy for primary insomnia.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

[Acupuncture and insomnia]

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

The effectiveness of acupressure in improving the quality of sleep of institutionalized residents.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

Identifying effective psychological treatments for insomnia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2801%2900003-3

7 January 2021

10.1016/S0095-4543(01)00003-3

Identifiers

DOI

1 reference

release_kdsvbdzqinapnmfxppyn4b27re

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kdsvbdzqinapnmfxppyn4b27re

24 November 2022

mapped directly with Wikidata item

1 reference